| Basics |
|
Embecta Corp.
|
| IPO Date: |
April 1, 2022 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers - Specialty and Generic |
| Market Cap: |
$836.34M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.43 | 2.18%
|
| Avg Daily Range (30 D): |
$0.26 | 1.80%
|
| Avg Daily Range (90 D): |
$0.26 | 2.16%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.46M |
| Avg Daily Volume (30 D): |
.27M |
| Avg Daily Volume (90 D): |
.39M |
| Trade Size |
| Avg Trade Size (Sh.): |
60 |
| Avg Trade Size (Sh.) (30 D): |
43 |
| Avg Trade Size (Sh.) (90 D): |
51 |
| Institutional Trades |
| Total Inst.Trades: |
1,403 |
| Avg Inst. Trade: |
$2.23M |
| Avg Inst. Trade (30 D): |
$1.51M |
| Avg Inst. Trade (90 D): |
$1.61M |
| Avg Inst. Trade Volume: |
.1M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.46M |
| Avg Closing Trade (30 D): |
$1.53M |
| Avg Closing Trade (90 D): |
$1.66M |
| Avg Closing Volume: |
115.58K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$.78
|
$.4
|
$
|
|
Diluted EPS
|
$.78
|
$.4
|
$
|
|
Revenue
|
$ 295.5M
|
$ 259M
|
$ 261.9M
|
|
Gross Profit
|
$ 197.1M
|
$ 164.1M
|
$ 157.1M
|
|
Net Income / Loss
|
$ 45.5M
|
$ 23.5M
|
$ M
|
|
Operating Income / Loss
|
$ 94M
|
$ 62.9M
|
$ 28.7M
|
|
Cost of Revenue
|
$ 98.4M
|
$ 94.9M
|
$ 104.8M
|
|
Net Cash Flow
|
$ 18.2M
|
$
|
$
|
|
PE Ratio
|
0.00
|
|
|
|
|
|